These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4575344)

  • 1. [The use of Wittenborn psychiatric rating scales in geriatric psychiatry. Results of a double blind study with cyprodenate and placebo].
    Bergener M; Freistein H
    Arzneimittelforschung; 1972 Dec; 22(12):2058-63. PubMed ID: 4575344
    [No Abstract]   [Full Text] [Related]  

  • 2. Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
    Goldstein SE; Birnbom F
    J Clin Psychiatry; 1979 Dec; 40(12):520-4. PubMed ID: 500575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of placebo effect in functional psychoses.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1973 Mar; 15(1):53-4. PubMed ID: 4572683
    [No Abstract]   [Full Text] [Related]  

  • 4. Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.
    Nair NP; Ban TA; Hontela S; Clarke R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):769-75. PubMed ID: 4201974
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
    Ban TA; Lehmann HE; Amin M; Bronheim LA; Klingner A; Nair NP; Galvan L; Vergara L; Zoch C
    Int J Clin Pharmacol; 1974 Jan; 9(1):23-7. PubMed ID: 4593127
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.
    Leckman J; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(4):301-3. PubMed ID: 4932747
    [No Abstract]   [Full Text] [Related]  

  • 7. Rating scales in psychopharmacology. Statistical aspects.
    Bech P
    Acta Psychiatr Belg; 1988; 88(4):291-302. PubMed ID: 3078609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A review of the more important evaluation scales in geriatrics].
    Bidzan L
    Psychiatr Pol; 1986; 20(6):489-96. PubMed ID: 3299435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiothixene in childhood psychoses.
    Simeon J; Saletu B; Saletu M; Itil TM; DaSilva J
    Adv Biochem Psychopharmacol; 1974; 9(0):519-34. PubMed ID: 4599439
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of SKF-14336 in the treatment of psychosis associated with organic brain syndrome.
    Goldstein BJ; Jacobson S
    Dis Nerv Syst; 1969 Jan; 30(1):37-41. PubMed ID: 4887216
    [No Abstract]   [Full Text] [Related]  

  • 12. [The problem of quantification in psychiatric research].
    Pichot P
    Bull Schweiz Akad Med Wiss; 1970 Jan; 25(1-2):147-59. PubMed ID: 4908657
    [No Abstract]   [Full Text] [Related]  

  • 13. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double blind study as evidence of the therapeutic effect of Melissengeist on psycho-vegetative syndromes (author's transl)].
    Büchner KH; Hellings H; Huber M; Peukert E; Späth L; Deininger R
    Med Klin; 1974 Jun; 69(23):1032-6. PubMed ID: 4603097
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of a phase II study of the antidepressant effect of rolipram.
    Zeller E; Stief HJ; Pflug B; Sastre-y-Hernández M
    Pharmacopsychiatry; 1984 Nov; 17(6):188-90. PubMed ID: 6393150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the problem of drug testing in geriatrics].
    Kleinsorge H; Rahlfs V
    Arzneimittelforschung; 1969 Apr; 19(4):623-8. PubMed ID: 4891525
    [No Abstract]   [Full Text] [Related]  

  • 17. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A differential description of the SDAT (senile dementia Alzheimer type) patient using 2 behavior observation scales: the BOP (Older Patients Rating Scale) and the GOS-G (Behavior Observation Scale-Geriatrics)].
    Gorissen JP
    Tijdschr Gerontol Geriatr; 1986 Feb; 17(1):17-24. PubMed ID: 3952782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camazepam versus placebo. A double-blind clinical study on geriatric patients suffering from psychic complaints. Short Communication.
    Tammaro A; Picceo MT; Gemmellaro P; Bonaccorso O
    Arzneimittelforschung; 1977; 27(11):2177-8. PubMed ID: 23793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.